Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Analyzing the Growth Rate of the Antidiabetics Market: What’s the Expected CAGR for the Next Decade?

The size of the antidiabetics market has seen a swift expansion in the preceding few years. The market is anticipated to escalate from $76.03 billion in 2024 to reach a value of $84.84 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.6%. Aspects such as the increasing prevalence of diabetes globally, advancements in medication formulation, escalation in the rates of diagnosis due to enhanced awareness, government policies supporting healthcare, an upward shift in geriatric population, inactive lifestyles and soaring expenditure on health care have all contributed to the market growth during the historical period.

The size of the antidiabetics market is projected to experience swift expansion in the coming years, reaching a value of $130.12 billion by 2029, with a compound annual growth rate (CAGR) of 11.3%. This surge during the projection period can be credited to the escalating instances of diabetes, enhanced awareness and detection, growth in healthcare costs, swelling senior citizen population, and initiatives and health policies by the government. Notable trends during the prediction timeframe involve the growth in GLP-1 receptor agonists and SGLT2 inhibitors, the burgeon in biologics and biosimilars, emphasis on prophylactic health care, the emergence of new markets, and the integration of technology.

How Are the key drivers expanding the growth of the Antidiabetics Market?

The growth of the antidiabetic market is anticipated to be fueled by an increasing prevalence of ailments tied to lifestyle habits. These health problems stem from or are magnified by actions such as unhealthy eating, insufficient exercise, smoking, and excessive alcohol intake. The growth of these lifestyle-related diseases is being driven by subpar diets, lack of physical activity, and heightened stress levels. Antidiabetic drugs can help manage these lifestyle-related conditions such as obesity and metabolic syndrome by enhancing insulin sensitivity and maintaining blood sugar control. For example, in March 2022, it was reported by the Switzerland-based World Health Organization, an intergovernmental entity, that approximately one billion people globally, being 650 million adults, 340 million adolescents, and 39 million children were battling obesity. This figure is steadily on the rise. By 2025, it is projected that 167 million adults and children will suffer health complications as a result of being overweight or obese. Hence, an escalating prevalence of lifestyle-related diseases is propelling the antidiabetic market.

Get Your Free Sample of the Global Antidiabetics Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=18225&type=smp

What Are the Leading Organizations Impacting the Antidiabetics Market’s Growth?

Major companies operating in the antidiabetics market are:

• Pfizer Inc.

• Johnson & Johnson

• Merck & Co. Inc.

• Bayer AG

• Sanofi S.A.

What Are the Most Prominent Trends Driving Change in the Antidiabetics Market?

Significant businesses in the antidiabetics market are innovating modern products such as the anti-diabetic biosimilar, which aids in better sugar management, lowers cardiovascular event risk, and presents more successful treatment possibilities for diabetics. An anti-diabetic biosimilar resembles a formerly approved diabetes treatment reference drug in its biological identity, providing similar efficiency, safety, and quality. For instance, Glenmark Pharmaceuticals Limited, hailing from India, launched Liraglutide’s first biosimilar, an anti-diabetic medication, in January 2024. This biosimilar, released under the name Lirafit, enhances glycemic control in adults suffering from type 2 diabetes mellitus. Clinical studies demonstrate it positively affects glycemic factors, aids weight loss, and boosts cardiovascular safety. As a GLP-1 receptor agonist, it stimulates insulin secretion dependent on glucose and lowers unsuitable glucagon secretion. It has received global approval for administering type 2 diabetes in adults.

Get Instant Access to the Global Antidiabetics Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/antidiabetics-global-market-report

Which Key Segments of the Antidiabetics Market Are Poised for Growth and Innovation?

The antidiabetics market covered in this report is segmented –

1) By Drug Class: Insulin, GLP-1 Receptor Agonists, DPP- 4 Inhibitors, SGLT2 Inhibitors, Other Drug Classes,

2) By Diabetes Type: Type 1, Type 2

3) By Patient Population: Antidiabetics For Pediatrics, Antidiabetics For Adults, Antidiabetics For Geriatrics

4) By Route Of Administration: Antidiabetics Administration Through Insulin Syringes Or Insulin Pens, Antidiabetics Administration Through Insulin Pumps, Intravenous Antidiabetics Infusion, Oral Antidiabetics Administration, Other Routes Of Antidiabetics Administration

5) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies

Subsegments:

1) By Insulin: Rapid-Acting Insulin, Short-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin, Premixed Insulin

2) By GLP-1 Receptor Agonists: Exenatide, Liraglutide, Dulaglutide, Semaglutide, Lixisenatide

3) By DPP-4 Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin

4) By SGLT2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin

5) By Other Drug Classes: Sulfonylureas, Thiazolidinediones (TZDs), Alpha-Glucosidase Inhibitors, Meglitinides, GLP-1/Insulin Combination Therapy

What Regions Are Leading the Charge in the Antidiabetics Market?

North America was the largest region in the antidiabetics market in 2023. The regions covered in the antidiabetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Parameters Define the Antidiabetics Market’s Scope?

Antidiabetics are a class of medications used to treat diabetes mellitus, a condition characterized by high blood glucose levels. These medications help control blood sugar levels in various ways, depending on the type of diabetes and the mechanism of the drug. Antidiabetics manage blood sugar levels, reduce complications, improve health outcomes, enhance metabolic control and insulin sensitivity, offer customized treatment options, and provide additional benefits such as weight management and cardiovascular protection.

Browse Through More Similar Reports By The Business Research Company:

Anti-Hypertensive Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Anti-Thyroid Drugs Global Market Report 2019

https://www.thebusinessresearchcompany.com/report/antithyroid-drugs-global-market-report

Antithrombotic Drugs Global Market Opportunities And Strategies To 2030

https://www.thebusinessresearchcompany.com/report/antithrombotic-drugs-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: